Stockreport

Nexalin Technology Receives Notice of Allowance from the USPTO for Patent Covering Deep Intracranial Frequency Stimulation (DIFS™) Technology for Opioid and Other Substance Use Disorders [...

Nexalin Technology, Inc.  (NXL) 
PDF Addressing Substance Use Disorders, Including Opioids, Alcohol, Cocaine and Methamphetamine HOUSTON, TX, March 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (N [Read more]